Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium

Ryou Watanabe, Toru Nakazawa, Shunji Yokokura, Akira Kubota, Hisayo Kubota, Kohji NishidaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, JapanBackground: In vitro studies have suggested the corneal cytotoxicity of third-generation fluoroquinolone levoflox...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ryou Watanabe, Toru Nakazawa, Shunji Yokokura, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Acceso en línea:https://doaj.org/article/debfb31372114e5fa7da333a66703145
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:debfb31372114e5fa7da333a66703145
record_format dspace
spelling oai:doaj.org-article:debfb31372114e5fa7da333a667031452021-12-02T04:55:41ZFluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium1177-54671177-5483https://doaj.org/article/debfb31372114e5fa7da333a667031452010-10-01T00:00:00Zhttp://www.dovepress.com/fluoroquinolone-antibacterial-eye-drops-effects-on-normal-human-cornea-a5451https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Ryou Watanabe, Toru Nakazawa, Shunji Yokokura, Akira Kubota, Hisayo Kubota, Kohji NishidaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, JapanBackground: In vitro studies have suggested the corneal cytotoxicity of third-generation fluoroquinolone levofloxacin (LVFX) and fourth-generation fluoroquinolone moxifloxacin hydrochloride (MFLX) among fluoroquinolone antibacterial eye drops. This study investigated the effects of these two eye drops on the human cornea in vivo.Methods: We evaluated 30 healthy adults (19 men and 11 women, 38.3 ± 6.3 years old). Each subject received an LVFX ophthalmic solution 0.5% in one eye and an MFLX ophthalmic solution 0.5% in the other eye three times daily for 7 days. Functional and morphological corneal changes before and after instillation were evaluated through ophthalmic examinations including breakup time of tear film (BUT) as measured by fluorescein staining and DR-1, Schirmer I test, Heidelberg Retina Tomograph II Rostock Cornea Module (HRTII-RCM), specular microscope, and Pentacum examination.Results: Both the LVFX and MFLX groups had no significant change in each examination before and after instillation. There was also no statistically significant difference in measurements after the 7-day instillation between the groups.Conclusion: Our study results suggest that as with LVFX, MFLX used in a normal clinical setting is unlikely to cause any obvious adverse effects on human normal cornea.Keywords: cornea, fluoroquinolones, ocular surface, toxicity Ryou WatanabeToru NakazawaShunji Yokokuraet alDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2010, Iss default, Pp 1181-1187 (2010)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Ryou Watanabe
Toru Nakazawa
Shunji Yokokura
et al
Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
description Ryou Watanabe, Toru Nakazawa, Shunji Yokokura, Akira Kubota, Hisayo Kubota, Kohji NishidaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, JapanBackground: In vitro studies have suggested the corneal cytotoxicity of third-generation fluoroquinolone levofloxacin (LVFX) and fourth-generation fluoroquinolone moxifloxacin hydrochloride (MFLX) among fluoroquinolone antibacterial eye drops. This study investigated the effects of these two eye drops on the human cornea in vivo.Methods: We evaluated 30 healthy adults (19 men and 11 women, 38.3 ± 6.3 years old). Each subject received an LVFX ophthalmic solution 0.5% in one eye and an MFLX ophthalmic solution 0.5% in the other eye three times daily for 7 days. Functional and morphological corneal changes before and after instillation were evaluated through ophthalmic examinations including breakup time of tear film (BUT) as measured by fluorescein staining and DR-1, Schirmer I test, Heidelberg Retina Tomograph II Rostock Cornea Module (HRTII-RCM), specular microscope, and Pentacum examination.Results: Both the LVFX and MFLX groups had no significant change in each examination before and after instillation. There was also no statistically significant difference in measurements after the 7-day instillation between the groups.Conclusion: Our study results suggest that as with LVFX, MFLX used in a normal clinical setting is unlikely to cause any obvious adverse effects on human normal cornea.Keywords: cornea, fluoroquinolones, ocular surface, toxicity
format article
author Ryou Watanabe
Toru Nakazawa
Shunji Yokokura
et al
author_facet Ryou Watanabe
Toru Nakazawa
Shunji Yokokura
et al
author_sort Ryou Watanabe
title Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
title_short Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
title_full Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
title_fullStr Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
title_full_unstemmed Fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
title_sort fluoroquinolone antibacterial eye drops: effects on normal human corneal epithelium, stroma, and endothelium
publisher Dove Medical Press
publishDate 2010
url https://doaj.org/article/debfb31372114e5fa7da333a66703145
work_keys_str_mv AT ryouwatanabe fluoroquinoloneantibacterialeyedropseffectsonnormalhumancornealepitheliumstromaandendothelium
AT torunakazawa fluoroquinoloneantibacterialeyedropseffectsonnormalhumancornealepitheliumstromaandendothelium
AT shunjiyokokura fluoroquinoloneantibacterialeyedropseffectsonnormalhumancornealepitheliumstromaandendothelium
AT etal fluoroquinoloneantibacterialeyedropseffectsonnormalhumancornealepitheliumstromaandendothelium
_version_ 1718400982868557824